select search filters
briefings
roundups & rapid reactions
before the headlines
Fiona fox's blog
Journalists were able to join our speakers, Professor Sir Peter Horby and Professor Sir Martin Landray, Chief Investigators of the RECOVERY trial, who provided results on the use of Regeneron’s monoclonal antiviral antibody combination as a potential treatment for patients hospitalised with COVID-19.
Speakers included:
Prof Peter Horby, Professor of Emerging Infectious Diseases and Global Health in the Nuffield Department of Medicine, University of Oxford, and Chief Investigator of the RECOVERY trial
Prof Martin Landray, Professor of Medicine and Epidemiology at the Nuffield Department of Population Health, University of Oxford, and Deputy Chief Investigator of the RECOVERY trial
This Briefing was accompanied by an SMC Roundup of Comments.